Dr. Zeytinoglu is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
180 Harvester Dr Ste 110
Burr Ridge
Chicago, IL 60637Phone+1 773-702-6138Fax+1 773-834-0486
Education & Training
University of ChicagoFellowship, Endocrinology, Diabetes, and Metabolism, 2013 - 2016- University of ChicagoResidency, Internal Medicine, 2011 - 2013
Johns Hopkins Bloomberg School of Public HealthResidency, Public Health and General Preventive Medicine, 2010 - 2011- University of ChicagoResidency, Internal Medicine, 2009 - 2010
Indiana University School of MedicineClass of 2008
Certifications & Licensure
IL State Medical License 2012 - 2026
MD State Medical License 2010 - 2011
Publications & Presentations
PubMed
- 1 citationsTirzepatide Improved Markers of Islet Cell Function and Insulin Sensitivity in People With T2D (SURPASS-2).Juan P Frias, Christophe De Block, Katelyn Brown, Hui Wang, Melissa K Thomas
The Journal of Clinical Endocrinology and Metabolism. 2024-06-17 - 1 citationsReduction of prevalence of patients meeting the criteria for metabolic syndrome with tirzepatide: a post hoc analysis from the SURPASS Clinical Trial Program.Stephen J Nicholls, Santiago Tofé, Carel W le Roux, David A D'Alessio, Russell J Wiese
Cardiovascular Diabetology. 2024-02-10 - 13 citationsObesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation.Sandra C Naaman, Sherry Shen, Meltem Zeytinoglu, Neil M Iyengar
The Journal of Clinical Endocrinology and Metabolism. 2022-07-14
Press Mentions
This Is What Happens One Hour After Drinking a Can of SodaMarch 22nd, 2019
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
